local_hospital

Nij Geertgen

Address
Ripseweg 9, 5424SM Elsendorp, The Netherlands

Nij Geertgen - Reproductive Medicine and Fertility Research

Nij Geertgen is a specialized medical research center focused on advancing reproductive medicine and fertility treatments. The center conducts clinical trials investigating innovative approaches to improve outcomes for couples experiencing difficulties conceiving, with particular emphasis on optimizing assisted reproductive technologies.

  • Unexplained subfertility and infertility treatment optimization
  • Intra-uterine insemination (IUI) with mild ovarian hyperstimulation protocols
  • Progesterone luteal phase support interventions

The research team at Nij Geertgen is committed to evidence-based fertility care, conducting comprehensive studies such as the LUMO study that evaluate both clinical efficacy and cost-effectiveness of treatment modifications. Their work focuses on cumulative live birth rate improvement through careful investigation of hormonal support protocols in conjunction with FSH-based mild ovarian stimulation, ultimately aiming to enhance success rates for couples undergoing fertility treatments.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 271 other sites in The Netherlands

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
5areas
Outperforms 69% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — The Netherlands

Select a therapeutic area to compare against other sites in The Netherlands.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: The Netherlands

Market Share

Country: The Netherlands

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Nij Geertgen

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Letrozole Versus Gonadotropins for Ovulation Induction in Polycystic Ovary Syndrome: A Randomized Clinical TrialAmsterdam UMC StichtingPhase IIIRecruitingAug 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Follitropin Alfa1Unknown2025-08-012025-08-01

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.